• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

How the Simple Telehealth Visit Will Revolutionize Care Delivery and Disease Management

Share:

September 16, 2020

The impact of COVID-19 on the healthcare industry’s ability to innovate has been stunning. We have seen FDA emergency authorizations and relaxed regulatory guidelines enable the development of radical new ventilator ideas, accelerated timelines for vaccine development, and an extraordinary transition to telehealth services. Many of these actions were a response to the exposure of weak spots in our healthcare system, but even as those weaknesses have been shored up (in large part due to public health orders on masks, social distancing, and limits on gatherings), the use of telehealth visits is showing remarkable staying power.

New data from IQVIA shows that as states have reopened, telehealth visits have remained up by 2,500% from their pre-COVID levels. While it is clear people have experienced convenience benefits from telehealth visits, telehealth will likely remain a dominant channel of communication between patients and their healthcare providers (HCPs) after HIPPA compliance is reinstated. This presents a huge opportunity for HCPs and payers. Now that we have the attention of clinicians and patients, the telehealth channel has the potential to expand beyond “virtual visits.” The sheer volume of data generated through this channel, integrated with clinical and claims data, has the potential to create value that extends into wellness and prevention, as well as care management and treatment. In addition to the potential benefits for individual patients, digital health solutions keep people out of the clinic and help keep our most vulnerable communities safe.

As the rules of the new normal continue to be written, we believe HCPs and payers should reframe telehealth from the digitization of the old model and see it as the epicenter of the future of healthcare.

Step 1: Define and prioritize the health profile in the populations you serve

HCPs and payers should identify and prioritize the healthcare needs of the populations they serve. How much of your population is on Medicare? What percentage have diabetes, congestive heart failure, or chronic obstructive pulmonary disease? How many would benefit from improved access to mental health services? How much care can be provided without having to touch and examine the body? Asking questions like these will help healthcare organizations segment their market by care needs and the degree of prevention, management, and treatment services that they can offer virtually.

Step 2: Create a build/buy/partner strategy for digital health solutions

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Based on a prioritized assessment of the population, HCP and payers should immerse themselves in the startup ecosystem around digital health and identify companies whose value propositions are aligned with the needs of their care needs segmentation. This is a key first phase of a build/buy/partner strategy. There are several digital therapeutics (DTx) and digital health startups, such as Omada and Virta, that are succeeding at providing solutions like individualized nutrition therapy and activity guidance to help people manage and prevent diabetes. Solutions like these may be ready to plug into existing systems and workflows. Or they may serve as inspiration for how to better deliver care.

Step 3: Nudge your patients along

With telehealth visits, HCP and payers have the attention of their patients, as well as their data. Patients can be introduced to resources that can help them better understand their own health, establish pathways to improving their health and wellness, and even receive prevention and treatment services akin to Omada, Virta, reSET-O, and other DTx. The benefits of these resources can be measured in terms of reduced hospital admissions and comorbidities, not to mention an improvement in overall quality of life. HCP and payers can use the platform to gently introduce their patients to these features and keep them relevant through encouragement, coaching, and personalization.

This pandemic has already carved out its place in world history. And years from now, when we look back on COVID-19’s impact on society, we will likely see at least one positive aspect of its legacy – a global population with better access to quality care from a system that is affordable by all.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Essity Acquires 75% of the Medical Solutions Company ABIGO Medical ABEssity Acquires 75% of the Medical Solutions Company ABIGO Medical AB
  • Madison Dearborn Partners Completes Acquisition of Benefytt TechnologiesMadison Dearborn Partners Completes Acquisition of Benefytt Technologies
  • Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)Paradigm Therapeutics Acquires Late Stage “Breakthrough Therapy” Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB)
  • Artificial Intelligence in Drug Discovery Global Market Report 2022: Rise in Demand for a Reduction in the Overall Time Taken for the Drug Discovery Process is a Key Driver Propelling Growth – ResearchAndMarkets.comArtificial Intelligence in Drug Discovery Global Market Report 2022: Rise in Demand for a Reduction in the Overall Time Taken for the Drug Discovery Process is a Key Driver Propelling Growth – ResearchAndMarkets.com
  • Less Than 10% of Suicide Prevention Apps Cover all the Recommended Strategies: NTU SingaporeLess Than 10% of Suicide Prevention Apps Cover all the Recommended Strategies: NTU Singapore
  • Amino Health Receives $42M Credit Facility.Amino Health Receives $42M Credit Facility.
  • Active Pharmaceutical Ingredient Market to Hit USD 261.28 Billion and Exhibit 6.1% CAGR by 2026Active Pharmaceutical Ingredient Market to Hit USD 261.28 Billion and Exhibit 6.1% CAGR by 2026
  • Lilly Completes Acquisition of Sigilon TherapeuticsLilly Completes Acquisition of Sigilon Therapeutics

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications